Its a new medication still in development, and it works by mimicking three gut hormones, GIP , GLP-1 , and Glucagon which that help regulate appetite, metabolism, and fat breakdown
The SURMOUNT-4 trial with tirzepatide showed that participants who continued the medication lost an additional 5.5% of their body weight, while those who switched to a placebo regained 14%
There are potential side effects for both drugsand they typically involve gut troubles, as both drugs work in the GI tract, Maselli says
Talk to a licensed healthcare professional about your weight loss goals
John Stanford, the executive director of Incubate Coalition, a Washington-based group of life-sciences investors, said investors are worried about diminishing exits if large drug companies have fewer funds to make acquisitions
1 Contraindications or require Caution: individuals who are pregnant or breastfeeding, have a history of cancer, or have pre-existing liver or kidney conditions